Detalles de la búsqueda
1.
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Ann Hematol
; 103(1): 125-132, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731147
2.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax.
Am J Hematol
; 98(4): E80-E83, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651870
3.
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.
Biomedicines
; 11(2)2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36830896
4.
CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature.
Front Oncol
; 13: 1291457, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38333543
5.
Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4+ and CD8+ T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther
; 27(6): 518.e1-518.e4, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33812803
6.
WT1 - Gene expression driven pre-emptive treatment with decitabine for molecular relapse of acute myeloid leukemia after allogeneic stem cell transplant.
Leuk Res
; 108: 106587, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34020318
Resultados
1 -
6
de 6
1
Próxima >
>>